[HTML][HTML] Papillary thyroid cancer: genetic alterations and molecular biomarker investigations
MI Abdullah, SM Junit, KL Ng… - … journal of medical …, 2019 - ncbi.nlm.nih.gov
Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of
the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is …
the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is …
The role of S100A6 in human diseases: molecular mechanisms and therapeutic potential
F Yang, J Ma, D Zhu, Z Wang, Y Li, X He, G Zhang… - Biomolecules, 2023 - mdpi.com
S100A6, also known as calcyclin, is a low-molecular-weight Ca2+-binding protein from the
S100 family that contains two EF-hands. S100A6 is expressed in a variety of mammalian …
S100 family that contains two EF-hands. S100A6 is expressed in a variety of mammalian …
S100A6: molecular function and biomarker role
Y Wang, X Kang, X Kang, F Yang - Biomarker Research, 2023 - Springer
S100A6 (also called calcyclin) is a Ca2+-binding protein that belongs to the S100 protein
family. S100A6 has many functions related to the cytoskeleton, cell stress, proliferation, and …
family. S100A6 has many functions related to the cytoskeleton, cell stress, proliferation, and …
The potential of metabolomics in the diagnosis of thyroid cancer
Thyroid cancer is the most common endocrine system malignancy. However, there is still a
lack of reliable and specific markers for the detection and staging of this disease. Fine …
lack of reliable and specific markers for the detection and staging of this disease. Fine …
[HTML][HTML] Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy
Around 5% of the general population have palpable thyroid nodules. Although most thyroid
tumours are benign, thyroid cancer represents the most common malignancy of the …
tumours are benign, thyroid cancer represents the most common malignancy of the …
S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging
M Nipp, M Elsner, B Balluff, S Meding… - Journal of molecular …, 2012 - Springer
In papillary thyroid carcinoma (PTC), metastasis is a feature of an aggressive tumor
phenotype. To identify protein biomarkers that distinguish patients with an aggressive tumor …
phenotype. To identify protein biomarkers that distinguish patients with an aggressive tumor …
Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma
A Dinets, M Hulchiy, A Sofiadis… - European journal of …, 2012 - academic.oup.com
Background Increased incidence of papillary thyroid carcinoma (PTC) is observed as a
consequence of radiation exposure in connection to the Chornobyl nuclear plant accident in …
consequence of radiation exposure in connection to the Chornobyl nuclear plant accident in …
Application of machine learning for mass spectrometry-based multi-omics in thyroid diseases
Y Che, M Zhao, Y Gao, Z Zhang… - Frontiers in Molecular …, 2024 - frontiersin.org
Thyroid diseases, including functional and neoplastic diseases, bring a huge burden to
people's health. Therefore, a timely and accurate diagnosis is necessary. Mass spectrometry …
people's health. Therefore, a timely and accurate diagnosis is necessary. Mass spectrometry …
S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer
J Zhang, K Zhang, X Jiang, J Zhang - Digestive diseases and sciences, 2014 - Springer
Background Increased expression of S100A6 in many cancer tissues and its association
with tumor behavior and patient prognosis were demonstrated, and there are no studies …
with tumor behavior and patient prognosis were demonstrated, and there are no studies …
S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K/AKT/mTOR pathway
B Chen, D Zheng, C Liu, A Bhandari, S Hirachan… - … -Research and Practice, 2023 - Elsevier
High levels of S100A6 have been associated with progression in some types of human
cancers. Cancers related to S100A6 have been reported to include lung cancer, cervical …
cancers. Cancers related to S100A6 have been reported to include lung cancer, cervical …